Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Medicine, Science, and the Law
|
December 29, 2006
Arson: a growing inferno
Anand Jayaraman, John Frazer
Current Opinion in Biotechnology
|
November 1, 2005
Functional assays for screening GPCR targets
William Thomsen, John Frazer, David Unett
Cellular Signalling
|
June 22, 2018
Angiotensin (1-7) does not interact directly with MAS1, but can potently antagonize signaling from the AT1 receptor
Ibragim Gaidarov, John Adams, John Frazer, et al.
Cellular Signalling
|
April 1, 2025
Mechanisms of constitutive and agonist-induced 5-HT<sub>2B</sub> internalization, persistent endosomal signaling and paradoxical regulation of agonist pharmacology
Ibragim Gaidarov, John Frazer, Xiaohua Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 25, 2009
APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology
John W Adams, Juan Ramirez, Yunqing Shi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 20, 2013
Kinetics of 5-HT2B receptor signaling: profound agonist-dependent effects on signaling onset and duration
David J Unett, Joel Gatlin, Todd L Anthony, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 19, 2020
Discovery of a lead series of potent benzodiazepine 5-HT<sub>2C</sub> receptor agonists with high selectivity in functional and binding assays
Albert Ren, Xiuwen Zhu, Konrad Feichtinger, et al.
Journal of Medicinal Chemistry
|
May 14, 2025
Diazepine Agonists of the 5-HT<sub>2C</sub> Receptor with Unprecedented Selectivity: Discovery of Bexicaserin (LP352)
Albert Ren, Xiuwen Zhu, Juerg Lehmann, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 26, 2021
Novel (R)-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,n]naphthyridines as potent and selective agonists of the 5-HT<sub>2C</sub> receptor
Thomas O Schrader, Xiuwen Zhu, Michelle Kasem, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 17, 2008
Novel H3 receptor antagonists with improved pharmacokinetic profiles
Vincent J Santora, Jonathan A Covel, Rena Hayashi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Medicine, Science, and the Law
|
December 29, 2006
Arson: a growing inferno
Anand Jayaraman, John Frazer
Current Opinion in Biotechnology
|
November 1, 2005
Functional assays for screening GPCR targets
William Thomsen, John Frazer, David Unett
Cellular Signalling
|
June 22, 2018
Angiotensin (1-7) does not interact directly with MAS1, but can potently antagonize signaling from the AT1 receptor
Ibragim Gaidarov, John Adams, John Frazer, et al.
Cellular Signalling
|
April 1, 2025
Mechanisms of constitutive and agonist-induced 5-HT<sub>2B</sub> internalization, persistent endosomal signaling and paradoxical regulation of agonist pharmacology
Ibragim Gaidarov, John Frazer, Xiaohua Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 25, 2009
APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology
John W Adams, Juan Ramirez, Yunqing Shi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 20, 2013
Kinetics of 5-HT2B receptor signaling: profound agonist-dependent effects on signaling onset and duration
David J Unett, Joel Gatlin, Todd L Anthony, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 19, 2020
Discovery of a lead series of potent benzodiazepine 5-HT<sub>2C</sub> receptor agonists with high selectivity in functional and binding assays
Albert Ren, Xiuwen Zhu, Konrad Feichtinger, et al.
Journal of Medicinal Chemistry
|
May 14, 2025
Diazepine Agonists of the 5-HT<sub>2C</sub> Receptor with Unprecedented Selectivity: Discovery of Bexicaserin (LP352)
Albert Ren, Xiuwen Zhu, Juerg Lehmann, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 26, 2021
Novel (R)-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,n]naphthyridines as potent and selective agonists of the 5-HT<sub>2C</sub> receptor
Thomas O Schrader, Xiuwen Zhu, Michelle Kasem, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 17, 2008
Novel H3 receptor antagonists with improved pharmacokinetic profiles
Vincent J Santora, Jonathan A Covel, Rena Hayashi, et al.
Page
of 2